1. Home
  2. ETNB vs ARIS Comparison

ETNB vs ARIS Comparison

Compare ETNB & ARIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • ARIS
  • Stock Information
  • Founded
  • ETNB 2018
  • ARIS 2015
  • Country
  • ETNB United States
  • ARIS United States
  • Employees
  • ETNB 93
  • ARIS N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • ARIS Water Supply
  • Sector
  • ETNB Health Care
  • ARIS Utilities
  • Exchange
  • ETNB Nasdaq
  • ARIS Nasdaq
  • Market Cap
  • ETNB 1.2B
  • ARIS 828.1M
  • IPO Year
  • ETNB 2019
  • ARIS 2021
  • Fundamental
  • Price
  • ETNB $8.18
  • ARIS $29.01
  • Analyst Decision
  • ETNB Strong Buy
  • ARIS Buy
  • Analyst Count
  • ETNB 9
  • ARIS 6
  • Target Price
  • ETNB $29.63
  • ARIS $27.17
  • AVG Volume (30 Days)
  • ETNB 1.5M
  • ARIS 855.7K
  • Earning Date
  • ETNB 05-08-2025
  • ARIS 05-06-2025
  • Dividend Yield
  • ETNB N/A
  • ARIS 1.93%
  • EPS Growth
  • ETNB N/A
  • ARIS 36.59
  • EPS
  • ETNB N/A
  • ARIS 0.81
  • Revenue
  • ETNB N/A
  • ARIS $435,444,000.00
  • Revenue This Year
  • ETNB N/A
  • ARIS $8.98
  • Revenue Next Year
  • ETNB N/A
  • ARIS $7.68
  • P/E Ratio
  • ETNB N/A
  • ARIS $36.03
  • Revenue Growth
  • ETNB N/A
  • ARIS 11.05
  • 52 Week Low
  • ETNB $5.99
  • ARIS $12.44
  • 52 Week High
  • ETNB $13.71
  • ARIS $32.56
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 42.49
  • ARIS 52.98
  • Support Level
  • ETNB $6.88
  • ARIS $25.59
  • Resistance Level
  • ETNB $9.40
  • ARIS $30.95
  • Average True Range (ATR)
  • ETNB 0.66
  • ARIS 2.08
  • MACD
  • ETNB -0.22
  • ARIS 0.06
  • Stochastic Oscillator
  • ETNB 30.27
  • ARIS 52.67

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About ARIS Aris Water Solutions Inc.

Aris Water Solutions Inc is an environmental infrastructure and solutions company that helps customers reduce their water and carbon footprints. It has two primary revenue streams. The Produced Water Handling business gathers, transports, and, unless recycled, handles produced water generated from oil and natural gas production. The Water Solutions business develops and operates recycling facilities to treat, store and recycle produced water.

Share on Social Networks: